Talphera (TLPH) Research & Development (2010 - 2026)
Talphera (TLPH) recorded quarterly Research & Development of $1.6 million in Q1 2026, down 8.49% quarter-over-quarter from $1.8 million in Q3 2025, and up 41.15% on a YoY basis from $1.2 million in Q1 2025.
Talphera (TLPH) Research & Development (2010 - 2026) Analysis & Trends
Talphera's Research & Development history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Research & Development rose 41.15% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $6.1 million (down 5.14% YoY), while the FY2024 annual figure was $6.7 million, up 21.13% from the prior year.
- Research & Development was $1.6 million for Q1 2026 at Talphera, down from $1.8 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $2.1 million in Q3 2024 to a low of $612000.0 in Q4 2022.
- Historically, Research & Development has averaged $1.4 million across 5 years, with a median of $1.4 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Research & Development tumbled 43.57% in 2022, then surged 189.05% in 2023.
- A 5-year view of Research & Development shows it stood at $612000.0 in 2022, then soared by 189.05% to $1.8 million in 2023, then dropped by 25.21% to $1.3 million in 2024, then soared by 36.28% to $1.8 million in 2025, then declined by 8.49% to $1.6 million in 2026.
- The last three Research & Development figures came in at $1.6 million (Q1 2026), $1.8 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | Talphera | 59.35 Mn | 59.35 Mn | - | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.65 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 1.18 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.05 Mn |
| Dec 31, 2022 | 612,000.00 |
| Sep 30, 2022 | 799,000.00 |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 836,000.00 |
| Dec 31, 2021 | 986,000.00 |
| Sep 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 724,000.00 |
| Mar 31, 2021 | 969,000.00 |